Best Chemotherapy for breast cancer Doctors Worldwide — TOP 96

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Eda Tanrikulu specializes in medical oncology and chemotherapy, providing expert care at Anadolu Medical Center.

• Ranked 3rd in Turkey for minor specialty exam in 2013
• Experienced in international clinical studies in medical oncology
• Head of medical oncology unit at Haydarpaşa Numune Training and Research Hospital
• Graduated from top universities including Ankara and Marmara

Dr. Ari Raphael leads groundbreaking clinical trials and genomic medicine initiatives at Sourasky Medical Center, specializing in breast and lung cancer treatments.

• Primary investigator for multiple innovative oncology trials at TASMC
• Expert in comprehensive genomic profiling and liquid biopsies
• Honored as outstanding teacher at Tel-Aviv University Faculty of Medicine
• Active member of ESMO and IASLC professional societies

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, with decades of expertise in breast cancer treatment.

• Associate Professor of Oncology at Sackler Faculty of Medicine
• Specializes in sarcoma and breast cancer research
• Member of ESMO Sarcoma Faculty and ASCO
• Extensive experience in clinical trials and innovative therapies

Specialist in Oncological Gynecology and Radiotherapy – Tamar Sapra focuses on treating breast cancer at Sourasky Medical Center.

• Expertise in both chemotherapy and radiotherapy for gynecological cancers
• Dedicated to personalized treatment plans tailored to each patient's needs
• Works at one of Israel's leading medical centers

Professor Pfaffenbach has authored over 130 publications and leads the Department of Gastroenterology, Oncology, and Internal Medicine at Academic Hospital Solingen.

• Specializes in malignant tumors of internal organs, including breast cancer
• Board-certified in internal medicine and gastroenterology
• Member of the German Society of Gastroenterology and European Society of Gastroenterology
• Over 34 years of experience of experience in gastroenterology and oncology

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Prof. Sezer Sağlam specializes in gastrointestinal oncology with extensive experience in medical oncology. He works at Gayrettepe Florence Nightingale Hospital.

• Professor in Medical Oncology since 2016
• Fellowship-trained at Istanbul University
• Member of ESMO and ASCO
• Previously attended to gastrointestinal oncology cases

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Specializes in breast cancer surgery with a focus on neoadjuvant chemotherapy and breast-conserving techniques. Associate Professor at Atlas University Hospital.

• Over 29 years of experience of experience in general surgery, specializing in breast cancer
• Published multiple studies on the effectiveness of neoadjuvant chemotherapy in breast cancer treatment
• Certified in advanced breast cancer surgery techniques, including reconstruction and triple-negative cases
• Active participant in international breast cancer conferences and workshops

Children's hematologist specializing in bone marrow transplantation at SJD Barcelona Children's Hospital.

• Focuses on pediatric cases with dedicated expertise
• Specialized in bone marrow transplantation procedures
• Works at a renowned children's hospital in Barcelona

Dr. Graupera is an awarded pediatric oncologist and heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals.

• Trained at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA
• Specializes in neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors
• Recipient of multiple prestigious awards including from the American Society of Clinical Oncology
• Published over 70 papers on pediatric malignant tumors

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Solak specializes in breast cancer treatment after training at Hacettepe University and MD Anderson Cancer Center.

• Fellowship-trained at Hacettepe University Cancer Institute
• Experience treating various cancers including breast, lung, and ovarian
• Worked at MD Anderson Cancer Center – a world-renowned facility

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Professor Yesim Yildirim specializes in breast cancer immunotherapy and targeted therapies at Anadolu Medical Center, with over 80 international publications.

• Member of the European Society of Medical Oncology (ESMO)
• Author of 'Handbook of Advanced Cancer Care Treatment'
• Completed advanced oncology training at Rambam Medical Centre in Israel
• Professor at Haliç University, Istanbul

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.